# Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden

> **NCT04760184** · — · COMPLETED · sponsor: **Uppsala University** · enrollment: 20 (actual)

## Conditions studied

- Covid19
- Myeloma Multiple
- Malignant Lymphoma
- Hematologic Neoplasms
- Stem Cell Transplant Complications

## Interventions

- **OTHER:** Autologous stem cell transplantation

## Key facts

- **NCT ID:** NCT04760184
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-02-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04760184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04760184, "Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04760184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*